Does REMDESIVIR Cause Infusion site swelling? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Infusion site swelling have been filed in association with REMDESIVIR (Veklury). This represents 0.2% of all adverse event reports for REMDESIVIR.
24
Reports of Infusion site swelling with REMDESIVIR
0.2%
of all REMDESIVIR reports
0
Deaths
1
Hospitalizations
How Dangerous Is Infusion site swelling From REMDESIVIR?
Of the 24 reports, 1 (4.2%) required hospitalization.
Is Infusion site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMDESIVIR. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does REMDESIVIR Cause?
Off label use (1,092)
Alanine aminotransferase increased (1,047)
Death (808)
Aspartate aminotransferase increased (713)
Bradycardia (652)
Acute kidney injury (605)
Covid-19 (570)
Drug ineffective (497)
Liver function test increased (447)
Respiratory failure (394)
What Other Drugs Cause Infusion site swelling?
HUMAN IMMUNOGLOBULIN G (1,772)
TREPROSTINIL (1,686)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (241)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (194)
AMBRISENTAN (173)
INFLIXIMAB-DYYB (100)
INFLIXIMAB (98)
MACITENTAN (96)
VEDOLIZUMAB (57)
FOSCARBIDOPA\FOSLEVODOPA (55)
Which REMDESIVIR Alternatives Have Lower Infusion site swelling Risk?
REMDESIVIR vs REMERON
REMDESIVIR vs REMICADE
REMDESIVIR vs REMIFENTANIL
REMDESIVIR vs REMIMAZOLAM
REMDESIVIR vs REMODULIN